Overview of early response assessment in lymphoma with FDG-PET
- 1 January 2007
- journal article
- review article
- Published by E-MED LTD in Cancer Imaging
- Vol. 7 (1), 10-18
- https://doi.org/10.1102/1470-7330.2007.0004
Abstract
Overview of early response assessment in lymphoma with FDG-PET - Cancer Imaging Overview of early response assessment in lymphoma with FDG-PET - Early assessment of response to chemotherapy with fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) is becoming a routine part of management in patients with Hodgkin lymphoma (HL) and histologically aggressive non-Hodgkin lymphoma (NHL). Changes in FDG uptake can occur soon after the initiation of therapy and they precede changes in tumour volume. Recent studies in uniform populations of aggressive lymphomas (predominantly diffuse large B cell lymphomas) and HL have clarified the value of early response assessment with PET.Keywords
This publication has 57 references indexed in Scilit:
- High-dose sequential chemotherapy followed by autologous stem cell transplantation in relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a multicenter phase II studyAnnals of Oncology, 2005
- Intensity of18Fluorodeoxyglucose Uptake in Positron Emission Tomography Distinguishes Between Indolent and Aggressive Non-Hodgkin’s LymphomaJournal of Clinical Oncology, 2005
- Transformation in the use of radiation therapy of Hodgkin lymphoma: New concepts and indications lead to modern field design and are assisted by PET imaging and intensity modulated radiation therapy (IMRT)European Journal of Haematology, 2005
- Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphomaAnnals of Oncology, 2005
- Lymphoma: Diagnosis, staging, natural history, and treatment strategiesSeminars in Oncology, 2005
- Decreased 18F-FDG uptake 1 day after initiation of chemotherapy for malignant lymphomas.2004
- Contribution of PET imaging to the initial staging and prognosis of patients with Hodgkin's diseaseAnnals of Oncology, 2004
- Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging.1999
- A Prognostic Score for Advanced Hodgkin's DiseaseNew England Journal of Medicine, 1998
- Association between [ 18 F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observationEuropean Journal of Nuclear Medicine and Molecular Imaging, 1998